InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · Real-Time Price · USD
3.380
-0.080 (-2.31%)
At close: Jun 27, 2025, 4:00 PM
3.200
-0.180 (-5.33%)
After-hours: Jun 27, 2025, 7:59 PM EDT
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $4.08 million as of June 27, 2025. Its market cap has increased by 104.01% in one year.
Market Cap
4.08M
Enterprise Value
208.48K
1-Year Change
104.01%
Ranking
Category
Stock Price
$3.38
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $4.08M, a decrease of -84.31%. That is a compound annual growth rate of -33.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 4.10M | 20.59% |
| Dec 31, 2024 | 3.40M | 54.55% |
| Dec 29, 2023 | 2.20M | 15.79% |
| Dec 30, 2022 | 1.90M | -89.73% |
| Dec 31, 2021 | 18.50M | -19.57% |
| Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 217.42B |